Prostaglandin E2 is essential for efficacious skeletal muscle stem-cell function, augmenting regeneration and strength
Significance
Muscle repair after injury entails an immune response that orchestrates efficacious regeneration. Here we identify Prostaglandin E2 (PGE2) as a crucial inflammatory mediator of muscle stem cells (MuSCs), the building blocks of muscle regeneration. PGE2 is synthesized and secreted into the stem-cell niche in response to injury, leading to robust MuSC proliferation, key to myofiber repair. EP4 is the receptor that mediates PGE2 signaling in MuSCs, and genetically engineered mice that lack EP4 in MuSCs have impaired regeneration. Nonsteroidal anti-inflammatory drugs (NSAIDs), commonly used to treat pain after muscle injury, inhibit PGE2 synthesis, hinder muscle regeneration, and lead to weakened muscles. Importantly, a single treatment of injured muscles with PGE2 dramatically accelerates muscle repair and recovery of strength.
Top-30
Journals
1
2
3
4
5
|
|
International Journal of Molecular Sciences
5 publications, 3.18%
|
|
Scientific Reports
4 publications, 2.55%
|
|
Cell Reports
4 publications, 2.55%
|
|
Cells
3 publications, 1.91%
|
|
npj Regenerative Medicine
3 publications, 1.91%
|
|
Stem Cells International
3 publications, 1.91%
|
|
Journal of Applied Physiology
3 publications, 1.91%
|
|
Proceedings of the National Academy of Sciences of the United States of America
3 publications, 1.91%
|
|
Animals
2 publications, 1.27%
|
|
Frontiers in Cell and Developmental Biology
2 publications, 1.27%
|
|
Mechanisms of Ageing and Development
2 publications, 1.27%
|
|
Current Opinion in Genetics and Development
2 publications, 1.27%
|
|
Cell Stem Cell
2 publications, 1.27%
|
|
Advanced Science
2 publications, 1.27%
|
|
Annals of the New York Academy of Sciences
2 publications, 1.27%
|
|
Physiological Reports
2 publications, 1.27%
|
|
Science Translational Medicine
2 publications, 1.27%
|
|
eLife
2 publications, 1.27%
|
|
Science
1 publication, 0.64%
|
|
Journal of Clinical Investigation
1 publication, 0.64%
|
|
JCI insight
1 publication, 0.64%
|
|
Pharmacological Reviews
1 publication, 0.64%
|
|
Journal of Pharmacology and Experimental Therapeutics
1 publication, 0.64%
|
|
Applied Physiology, Nutrition and Metabolism
1 publication, 0.64%
|
|
Canadian Journal of Physiology and Pharmacology
1 publication, 0.64%
|
|
Environmental Health Perspectives
1 publication, 0.64%
|
|
New England Journal of Medicine
1 publication, 0.64%
|
|
Bioscience Reports
1 publication, 0.64%
|
|
International Journal of Molecular Medicine
1 publication, 0.64%
|
|
1
2
3
4
5
|
Publishers
5
10
15
20
25
30
35
40
45
|
|
Elsevier
42 publications, 26.75%
|
|
Springer Nature
26 publications, 16.56%
|
|
MDPI
16 publications, 10.19%
|
|
Wiley
12 publications, 7.64%
|
|
Cold Spring Harbor Laboratory
11 publications, 7.01%
|
|
Frontiers Media S.A.
7 publications, 4.46%
|
|
American Association for the Advancement of Science (AAAS)
4 publications, 2.55%
|
|
Taylor & Francis
4 publications, 2.55%
|
|
Hindawi Limited
4 publications, 2.55%
|
|
American Physiological Society
4 publications, 2.55%
|
|
Royal Society of Chemistry (RSC)
3 publications, 1.91%
|
|
Proceedings of the National Academy of Sciences (PNAS)
3 publications, 1.91%
|
|
American Society for Clinical Investigation
2 publications, 1.27%
|
|
American Society for Pharmacology and Experimental Therapeutics
2 publications, 1.27%
|
|
Canadian Science Publishing
2 publications, 1.27%
|
|
eLife Sciences Publications
2 publications, 1.27%
|
|
Environmental Health Perspectives
1 publication, 0.64%
|
|
Massachusetts Medical Society
1 publication, 0.64%
|
|
Spandidos Publications
1 publication, 0.64%
|
|
American Chemical Society (ACS)
1 publication, 0.64%
|
|
Oxford University Press
1 publication, 0.64%
|
|
Walter de Gruyter
1 publication, 0.64%
|
|
Rockefeller University Press
1 publication, 0.64%
|
|
PeerJ
1 publication, 0.64%
|
|
Radiation Research Society
1 publication, 0.64%
|
|
Georg Thieme Verlag KG
1 publication, 0.64%
|
|
American Society of Animal Science
1 publication, 0.64%
|
|
5
10
15
20
25
30
35
40
45
|
- We do not take into account publications without a DOI.
- Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
- Statistics recalculated weekly.